Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol and tiotropium comparison study in stable COPD
2004-002089-39Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Foradil Certihaler and tiotropium in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Novartis. Primary endpoint: FEV1 measured 2 hours post dosing after 24 weeks. Started Aug 2004; status: completed.
02
Drugs
Foradil Certihalertiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2004-002089-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002089-39.